Corbion proposes to re-appoint Olivier Rigaud as CEO
July 13 2022 - 1:00AM
Corbion proposes to re-appoint Olivier Rigaud as CEO
Corbion’s Supervisory Board announces
it has nominated Olivier Rigaud
for re-appointment as
CEO and
Chair of the Board of
Management for a second term of
office.
Olivier Rigaud was appointed in 2019 and his current term of
office runs from August 2019 to May 2023.
Chair of the Supervisory Board Mathieu Vrijsen said: "The
Supervisory Board is very pleased that Olivier is willing to extend
his contract of assignment with Corbion for a second four-year term
(May 2023 - May 2027). Since 2019, Olivier has been instrumental in
the further development of Corbion into a leading innovative,
sustainable solutions company, designing and successfully executing
the Advance 2025 growth strategy, and strengthening Corbion’s
commitment to the Preserve What Matters purpose. With his
re-appointment we establish continuity in leadership to further
drive the Advance 2025 strategy, and execute on our strategic
investment programs to enhance value creation for our shareholders
and our other stakeholders."
The proposed re-appointment is subject to shareholder approval
at the Annual General Meeting of Shareholders (AGM) that will be
held on 17 May 2023. The full details and agenda for the AGM will
be published in April 2023.
This press release contains inside information within the
meaning of Article 7(1) of the EU Market Abuse Regulation.
For more information, please contact:
Analysts and investors:Jeroen van Harten, Director Investor
Relations+31 (0)20 590 6323, +31(0)6 21 577 086
Press:Sanne Verhoeven, Director Corporate Communications+31
(0)20 590 6325, +31 (0)6 27 095 585
Background information:
Corbion is the global market leader in lactic acid and its
derivatives, and a leading supplier of emulsifiers, functional
enzyme blends, minerals, vitamins, and algae ingredients. We use
our unique expertise in fermentation and other processes to deliver
sustainable solutions for the preservation of food and food
production, health, and our planet. For over 100 years, we have
been uncompromising in our commitment to safety, quality,
innovation and performance. Drawing on our deep application and
product knowledge, we work side-by-side with customers to make our
cutting-edge technologies work for them. Our solutions help
differentiate products in markets such as food, home & personal
care, animal nutrition, pharmaceuticals, medical devices, and
bioplastics. In 2021, Corbion generated annual sales of € 1,070.8
million and had a workforce of 2,717 FTE. Corbion is listed on
Euronext Amsterdam. For more information: www.corbion.com
- 20220713 Announcement Rigaud ENG _final
Corbion N.V (EU:CRBN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Corbion N.V (EU:CRBN)
Historical Stock Chart
From Dec 2023 to Dec 2024
